^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Lyophilized formulation tested.

^d Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

^e Run at 21 mL/hr.

^f Given over five minutes by syringe pump.

^g Run at 94 mL/hr.

^h Tested in sterile water for injection.

ⁱ Tested in sodium chloride 0.45%.

^j Injected via Y-site into an administration set running azithromycin.

^k Tested in either dextrose 5% or in sodium chloride 0.9%, but the report did not specify which solution.

^l Tested in a 1:1 mixture of (1) dextrose 5% and dextrose 5% in sodium chloride 0.45% with and without potassium chloride 20 mEq/L and also in (2) dextrose 10% in sodium chloride 0.45% with and without potassium chloride 20 mEq/L.

ⁿ Quinupristin and dalfopristin components combined.

^o Test performed using the formulation WITH edetate disodium.